Applications

1242 – yttrium-90 microsphere radioembolisation to embolise the microvasculature of hepatic primary and secondary cancers

Find out about the service or technology in this application and the medical condition it addresses. You can also view the application documents, the deadlines for providing consultation input and the outcome of the application when the MSAC process is complete.

  • Status Complete
  • Type -
  • Pre-PASC consultation -
  • Pre-MSAC consultation -
  • Outcome -

Application details

Reason for application

-

Service or technology in this application

Trans-femoral catheterization of the hepatic artery to administer Y90-microspheres™ to embolise the microvasculature of hepatic metastases which are secondary to the liver or primary liver cancer.

Medical condition this application addresses

The Y90-Microspheres™ device is indicated for treatment of advanced liver cancer that is not amenable to surgical resection or regional ablation for cure.

Application documents

PICO confirmation

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Meetings to consider this application

  • PASC meeting:
    • 12 to 13 April 2012
    • 16 to 17 August 2012
  • ESC meeting: -
  • MSAC meeting: -